Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 369

1.

Hydroxyurea alters circulating monocyte subsets and dampens its inflammatory potential in sickle cell anemia patients.

Guarda CC, Silveira-Mattos PSM, Yahouédéhou SCMA, Santiago RP, Aleluia MM, Figueiredo CVB, Fiuza LM, Carvalho SP, Oliveira RM, Nascimento VML, Luz NF, Borges VM, Andrade BB, Gonçalves MS.

Sci Rep. 2019 Oct 15;9(1):14829. doi: 10.1038/s41598-019-51339-x.

PMID:
31616024
2.

Perivascular adipose tissue contributes to lethal sepsis-induced vasoplegia in rats.

Awata WMC, Gonzaga NA, Borges VF, Silva CBP, Tanus-Santos JE, Cunha FQ, Tirapelli CR.

Eur J Pharmacol. 2019 Sep 27;863:172706. doi: 10.1016/j.ejphar.2019.172706. [Epub ahead of print]

PMID:
31568782
3.

Thimet Oligopeptidase (EC 3.4.24.15) Key Functions Suggested by Knockout Mice Phenotype Characterization.

Santos NBD, Franco RD, Camarini R, Munhoz CD, Eichler RAS, Gewehr MCF, Reckziegel P, Llanos RP, Dale CS, Silva VROD, Borges VF, Lima BHF, Cunha FQ, Visniauskas B, Chagas JR, Tufik S, Peres FF, Abilio VC, Florio JC, Iwai LK, Rioli V, Presoto BC, Guimaraes AO, Pesquero JB, Bader M, Castro LM, Ferro ES.

Biomolecules. 2019 Aug 19;9(8). pii: E382. doi: 10.3390/biom9080382.

4.

Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer.

Lee GE, Rosenberg SM, Mayer EL, Borges V, Meyer ME, Schapira L, Come SE, Partridge AH.

Breast J. 2019 Jul 18. doi: 10.1111/tbj.13431. [Epub ahead of print]

PMID:
31318125
5.

Proteomic Analysis Reveals a Predominant NFE2L2 (NRF2) Signature in Canonical Pathway and Upstream Regulator Analysis of Leishmania-Infected Macrophages.

de Menezes JPB, Khouri R, Oliveira CVS, Petersen ALOA, de Almeida TF, Mendes FRL, Rebouças ADAD, Lorentz AL, Luz NF, Lima JB, Ramos PIP, Soares RP, Rugani JN, Buck GA, Krieger MA, Marchini FK, Vivarini ÁC, Lopes UG, Borges VM, Veras PST.

Front Immunol. 2019 Jun 28;10:1362. doi: 10.3389/fimmu.2019.01362. eCollection 2019.

6.

Health Innovation Laboratories: towards strong Primary Health Care (PHC)in the Federal District of Brasilia.

Tasca R, Ventura ILS, Borges V, Leles FAG, Gomes RM, Ribas AN, Carvalho WM, Jimenez JMS.

Cien Saude Colet. 2019 Jun 27;24(6):2021-2030. doi: 10.1590/1413-81232018246.08672019. Portuguese, English.

7.

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.

Korobeynikov V, Borakove M, Feng Y, Wuest WM, Koval AB, Nikonova AS, Serebriiskii I, Chernoff J, Borges VF, Golemis EA, Shagisultanova E.

Breast Cancer Res Treat. 2019 Sep;177(2):369-382. doi: 10.1007/s10549-019-05329-2. Epub 2019 Jun 28.

8.

PD-1 Blockade During Post-partum Involution Reactivates the Anti-tumor Response and Reduces Lymphatic Vessel Density.

Tamburini BAJ, Elder AM, Finlon JM, Winter AB, Wessells VM, Borges VF, Lyons TR.

Front Immunol. 2019 Jun 11;10:1313. doi: 10.3389/fimmu.2019.01313. eCollection 2019.

9.

Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia.

Nunes PR, Romão-Veiga M, Peraçoli JC, Araujo Costa RA, de Oliveira LG, Borges VTM, Peraçoli MT.

Immunol Res. 2019 Jun;67(2-3):194-201. doi: 10.1007/s12026-019-09078-8.

PMID:
31240481
10.

Pre-eclampsia/Eclampsia.

Peraçoli JC, Borges VTM, Ramos JGL, Cavalli RC, Costa SHAM, Oliveira LG, Souza FLP, Korkes HA, Brum IR, Nascimento MLCD, Corrêa Junior MD, Sass N, Diniz ALD, Cunha Filho EVD.

Rev Bras Ginecol Obstet. 2019 May;41(5):318-332. doi: 10.1055/s-0039-1687859. Epub 2019 Jun 10.

11.

Proficiency Testing of Virus Diagnostics Based on Bioinformatics Analysis of Simulated In Silico High-Throughput Sequencing Data Sets.

Brinkmann A, Andrusch A, Belka A, Wylezich C, Höper D, Pohlmann A, Nordahl Petersen T, Lucas P, Blanchard Y, Papa A, Melidou A, Oude Munnink BB, Matthijnssens J, Deboutte W, Ellis RJ, Hansmann F, Baumgärtner W, van der Vries E, Osterhaus A, Camma C, Mangone I, Lorusso A, Marcacci M, Nunes A, Pinto M, Borges V, Kroneman A, Schmitz D, Corman VM, Drosten C, Jones TC, Hendriksen RS, Aarestrup FM, Koopmans M, Beer M, Nitsche A.

J Clin Microbiol. 2019 Jul 26;57(8). pii: e00466-19. doi: 10.1128/JCM.00466-19. Print 2019 Aug.

12.

Employment trends in young women following a breast cancer diagnosis.

Rosenberg SM, Vaz-Luis I, Gong J, Rajagopal PS, Ruddy KJ, Tamimi RM, Schapira L, Come S, Borges V, de Moor JS, Partridge AH.

Breast Cancer Res Treat. 2019 Aug;177(1):207-214. doi: 10.1007/s10549-019-05293-x. Epub 2019 May 30.

PMID:
31147983
13.

Multiomics Assessment of Gene Expression in a Clinical Strain of CTX-M-15-Producing ST131 Escherichia coli.

Pinto L, Torres C, Gil C, Nunes-Miranda JD, Santos HM, Borges V, Gomes JP, Silva C, Vieira L, Pereira JE, Poeta P, Igrejas G.

Front Microbiol. 2019 May 3;10:831. doi: 10.3389/fmicb.2019.00831. eCollection 2019.

14.

Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.

Rath M, Li Q, Li H, Lindström S, Miron A, Miron P, Dowton AE, Meyer ME, Larson BG, Pomerantz M, Seo JH, Collins LC, Vardeh H, Brachtel E, Come SE, Borges V, Schapira L, Tamimi RM, Partridge AH, Freedman M, Ruddy KJ.

PLoS One. 2019 May 24;14(5):e0216997. doi: 10.1371/journal.pone.0216997. eCollection 2019.

15.

Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.

Wassermann J, Gelber SI, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, Borges VF, Come SE, Meyer ME, Partridge AH.

Cancer. 2019 Sep 15;125(18):3266-3274. doi: 10.1002/cncr.32192. Epub 2019 May 23.

PMID:
31120571
16.

Nontuberculous Mycobacteria Persistence in a Cell Model Mimicking Alveolar Macrophages.

Sousa S, Borges V, Joao I, Gomes JP, Jordao L.

Microorganisms. 2019 Apr 26;7(5). pii: E113. doi: 10.3390/microorganisms7050113.

17.

CteG is a Chlamydia trachomatis effector protein that associates with the Golgi complex of infected host cells.

Pais SV, Key CE, Borges V, Pereira IS, Gomes JP, Fisher DJ, Mota LJ.

Sci Rep. 2019 Apr 16;9(1):6133. doi: 10.1038/s41598-019-42647-3.

18.

Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis.

Colón DF, Wanderley CW, Franchin M, Silva CM, Hiroki CH, Castanheira FVS, Donate PB, Lopes AH, Volpon LC, Kavaguti SK, Borges VF, Speck-Hernandez CA, Ramalho F, Carlotti AP, Carmona F, Alves-Filho JC, Liew FY, Cunha FQ.

Crit Care. 2019 Apr 8;23(1):113. doi: 10.1186/s13054-019-2407-8.

19.

Evaluation of a gene-by-gene approach for prospective whole-genome sequencing-based surveillance of multidrug resistant Mycobacterium tuberculosis.

Macedo R, Pinto M, Borges V, Nunes A, Oliveira O, Portugal I, Duarte R, Gomes JP.

Tuberculosis (Edinb). 2019 Mar;115:81-88. doi: 10.1016/j.tube.2019.02.006. Epub 2019 Feb 25.

PMID:
30948181
20.

Specific characteristics of the medical history of swallowing before and after application of botulinum toxin in patients with cervical dystonia.

Vilanova TFDD, Borges V, Ferraz HB.

Clinics (Sao Paulo). 2019 Apr 1;74:e776. doi: 10.6061/clinics/2019/e776.

21.

Identifying distinct trajectories of change in young breast cancer survivors' sexual functioning.

von Hippel C, Rosenberg SM, Austin SB, Sprunck-Harrild K, Ruddy KJ, Schapira L, Come S, Borges VF, Partridge AH.

Psychooncology. 2019 May;28(5):1033-1040. doi: 10.1002/pon.5047. Epub 2019 Mar 13.

PMID:
30817075
22.

Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.

Contreras-Zárate MJ, Day NL, Ormond DR, Borges VF, Tobet S, Gril B, Steeg PS, Cittelly DM.

Oncogene. 2019 Jun;38(24):4685-4699. doi: 10.1038/s41388-019-0756-z. Epub 2019 Feb 22.

23.

Design of an industrial solid waste processing line to produce refuse-derived fuel.

Infiesta LR, Ferreira CRN, Trovó AG, Borges VL, Carvalho SR.

J Environ Manage. 2019 Apr 15;236:715-719. doi: 10.1016/j.jenvman.2019.02.017. Epub 2019 Feb 15.

PMID:
30772728
24.

CCR5-Positive Inflammatory Monocytes are Crucial for Control of Sepsis.

Castanheira FVES, de Lima KA, Cebinelli GCM, Sônego F, Kanashiro A, Colon DF, Borges V, Czaikoski PG, Mota JM, Cunha TM, Alves-Filho JC, Liew FY, Cunha FQ.

Shock. 2019 Nov;52(5):e100-e106. doi: 10.1097/SHK.0000000000001301.

PMID:
30724784
25.

Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.

Goddard ET, Bassale S, Schedin T, Jindal S, Johnston J, Cabral E, Latour E, Lyons TR, Mori M, Schedin PJ, Borges VF.

JAMA Netw Open. 2019 Jan 4;2(1):e186997. doi: 10.1001/jamanetworkopen.2018.6997.

26.

[Psychiatric care for abnormal children at the Hospital Colônia Sant'Ana (Santa Catarina, Brazil, 1940s)].

Borges VT, Caponi S.

Hist Cienc Saude Manguinhos. 2018 Oct-Dec;25(4):1239-1259. doi: 10.1590/S0104-59702018000500021. Portuguese.

27.

Genomic Study of a Clostridium difficile Multidrug Resistant Outbreak-Related Clone Reveals Novel Determinants of Resistance.

Isidro J, Menezes J, Serrano M, Borges V, Paixão P, Mimoso M, Martins F, Toscano C, Santos A, Henriques AO, Oleastro M.

Front Microbiol. 2018 Dec 6;9:2994. doi: 10.3389/fmicb.2018.02994. eCollection 2018.

28.

Lutzomyia longipalpis Saliva Induces Heme Oxygenase-1 Expression at Bite Sites.

Luz NF, DeSouza-Vieira T, De Castro W, Vivarini AC, Pereira L, França RR, Silveira-Mattos PS, Costa DL, Teixeira C, Meneses C, Boaventura VS, de Oliveira CI, Lopes UG, Aronson N, Andrade BB, Brodskyn CI, Valenzuela JG, Kamhawi S, Borges VM.

Front Immunol. 2018 Nov 28;9:2779. doi: 10.3389/fimmu.2018.02779. eCollection 2018.

29.

Innovations in Personalized and Targeted Therapies for Breast Cancer.

Harris EER, De Los Santos J, Borges VF, Grobmyer SR.

Int J Breast Cancer. 2018 Nov 14;2018:5409846. doi: 10.1155/2018/5409846. eCollection 2018. No abstract available.

PMID:
30538865
Free PMC Article
30.

Chemical characterization and biological activity of six different extracts of propolis through conventional methods and supercritical extraction.

Devequi-Nunes D, Machado BAS, Barreto GA, Rebouças Silva J, da Silva DF, da Rocha JLC, Brandão HN, Borges VM, Umsza-Guez MA.

PLoS One. 2018 Dec 4;13(12):e0207676. doi: 10.1371/journal.pone.0207676. eCollection 2018.

31.

Leishmania braziliensis Subverts Necroptosis by Modulating RIPK3 Expression.

Luz NF, Khouri R, Van Weyenbergh J, Zanette DL, Fiuza PP, Noronha A, Barral A, Boaventura VS, Prates DB, Chan FK, Andrade BB, Borges VM.

Front Microbiol. 2018 Sep 28;9:2283. doi: 10.3389/fmicb.2018.02283. eCollection 2018.

32.

Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer.

Pennock ND, Martinson HA, Guo Q, Betts CB, Jindal S, Tsujikawa T, Coussens LM, Borges VF, Schedin P.

J Immunother Cancer. 2018 Oct 1;6(1):98. doi: 10.1186/s40425-018-0406-y.

33.

Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer.

Elder AM, Tamburini BAJ, Crump LS, Black SA, Wessells VM, Schedin PJ, Borges VF, Lyons TR.

Cancer Res. 2018 Nov 15;78(22):6473-6485. doi: 10.1158/0008-5472.CAN-18-1642. Epub 2018 Sep 25.

PMID:
30254150
34.

Galectin-3 aggravates experimental polymicrobial sepsis by impairing neutrophil recruitment to the infectious focus.

Ferreira RG, Rodrigues LC, Nascimento DC, Kanashiro A, Melo PH, Borges VF, Gozzi A, da Silva Prado D, Borges MC, Ramalho FS, Stowell SR, Cummings RD, Dias-Baruffi M, Cunha FQ, Alves-Filho JC.

J Infect. 2018 Nov;77(5):391-397. doi: 10.1016/j.jinf.2018.06.010. Epub 2018 Jul 4.

PMID:
30226191
35.

RIPK1-RIPK3-MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils.

Barbosa LA, Fiuza PP, Borges LJ, Rolim FA, Andrade MB, Luz NF, Quintela-Carvalho G, Lima JB, Almeida RP, Chan FK, Bozza MT, Borges VM, Prates DB.

Front Immunol. 2018 Aug 14;9:1818. doi: 10.3389/fimmu.2018.01818. eCollection 2018.

36.

A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.

Greene LI, Bruno TC, Christenson JL, D'Alessandro A, Culp-Hill R, Torkko K, Borges VF, Slansky JE, Richer JK.

Mol Cancer Res. 2019 Jan;17(1):131-139. doi: 10.1158/1541-7786.MCR-18-0362. Epub 2018 Aug 24.

PMID:
30143553
37.

Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab.

Tobin RP, Jordan KR, Robinson WA, Davis D, Borges VF, Gonzalez R, Lewis KD, McCarter MD.

Int Immunopharmacol. 2018 Oct;63:282-291. doi: 10.1016/j.intimp.2018.08.007. Epub 2018 Aug 16.

38.

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.

Diamond JR, Eckhardt SG, Pitts TM, van Bokhoven A, Aisner D, Gustafson DL, Capasso A, Sams S, Kabos P, Zolman K, Colvin T, Elias AD, Storniolo AM, Schneider BP, Gao D, Tentler JJ, Borges VF, Miller KD.

Breast Cancer Res. 2018 Aug 2;20(1):82. doi: 10.1186/s13058-018-1014-y.

39.

Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition.

Schedin TB, Borges VF, Shagisultanova E.

Int J Breast Cancer. 2018 Jun 19;2018:7835095. doi: 10.1155/2018/7835095. eCollection 2018. Review.

40.

Phenotypic signatures and genetic determinants of oxacillin tolerance in a laboratory mutant of Staphylococcus aureus.

Chung M, Borges V, Gomes JP, de Lencastre H, Tomasz A.

PLoS One. 2018 Jul 3;13(7):e0199707. doi: 10.1371/journal.pone.0199707. eCollection 2018.

41.

Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.

Borges VF, Ferrario C, Aucoin N, Falkson C, Khan Q, Krop I, Welch S, Conlin A, Chaves J, Bedard PL, Chamberlain M, Gray T, Vo A, Hamilton E.

JAMA Oncol. 2018 Sep 1;4(9):1214-1220. doi: 10.1001/jamaoncol.2018.1812.

42.

INSaFLU: an automated open web-based bioinformatics suite "from-reads" for influenza whole-genome-sequencing-based surveillance.

Borges V, Pinheiro M, Pechirra P, Guiomar R, Gomes JP.

Genome Med. 2018 Jun 29;10(1):46. doi: 10.1186/s13073-018-0555-0.

43.

Correction for Pardos de la Gandara et al., "Genetic Determinants of High-Level Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus".

Pardos de la Gandara M, Borges V, Chung M, Milheiriço C, Gomes JP, de Lencastre H, Tomasz A.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e01096-18. doi: 10.1128/AAC.01096-18. Print 2018 Jul. No abstract available.

44.

A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer.

Stoen E, Kabos P, Borden KC, Brown RJ, Borges VF, Diamond JR.

Oncology (Williston Park). 2018 Jun;32(6):298-302. No abstract available.

45.

Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial.

Machado PRL, Ribeiro CS, França-Costa J, Dourado MEF, Trinconi CT, Yokoyama-Yasunaka JKU, Malta-Santos H, Borges VM, Carvalho EM, Uliana SRB.

Trop Med Int Health. 2018 Sep;23(9):936-942. doi: 10.1111/tmi.13119. Epub 2018 Jul 11.

46.

Mucosal Immunity in the Female Murine Mammary Gland.

Betts CB, Pennock ND, Caruso BP, Ruffell B, Borges VF, Schedin P.

J Immunol. 2018 Jul 15;201(2):734-746. doi: 10.4049/jimmunol.1800023. Epub 2018 Jun 8.

47.

Lutzomyia longipalpis Saliva Drives Interleukin-17-Induced Neutrophil Recruitment Favoring Leishmania infantum Infection.

Teixeira CR, Santos CDS, Prates DB, Dos Santos RT, Araújo-Santos T, de Souza-Neto SM, Borges VM, Barral-Netto M, Brodskyn CI.

Front Microbiol. 2018 May 8;9:881. doi: 10.3389/fmicb.2018.00881. eCollection 2018.

48.

Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study.

Murthy R, Borges VF, Conlin A, Chaves J, Chamberlain M, Gray T, Vo A, Hamilton E.

Lancet Oncol. 2018 Jul;19(7):880-888. doi: 10.1016/S1470-2045(18)30256-0. Epub 2018 May 24.

PMID:
29804905
49.

Leishmania infantum Lipophosphoglycan-Deficient Mutants: A Tool to Study Host Cell-Parasite Interplay.

Lázaro-Souza M, Matte C, Lima JB, Arango Duque G, Quintela-Carvalho G, de Carvalho Vivarini Á, Moura-Pontes S, Figueira CP, Jesus-Santos FH, Gazos Lopes U, Farias LP, Araújo-Santos T, Descoteaux A, Borges VM.

Front Microbiol. 2018 Apr 5;9:626. doi: 10.3389/fmicb.2018.00626. eCollection 2018.

50.

Bevacizumab for Refractory Gastrointestinal Bleeding in Rendu-Osler-Weber Disease.

Bernardes C, Santos S, Loureiro R, Borges V, Ramos G.

GE Port J Gastroenterol. 2018 Mar;25(2):91-95. doi: 10.1159/000481289. Epub 2017 Oct 5.

Supplemental Content

Loading ...
Support Center